Citizen Petition from Attorney General of Massachusetts, et al.

The Catholic Medical Association (CMA) opposes the proposed changes to mifepristone regulations, arguing that the petition relies on biased data and fails to account for the serious physical, psychological, and ethical risks of chemical abortion. They advocate for strengthening current safety safeguards, including mandatory in-person consultations and more comprehensive informed consent requirements.

The Catholic Medical Association (CMA) opposes the petition to reduce or eliminate safety regulations (REMS and EASU) for mifepristone. They argue that the petition relies on biased data that underestimates serious adverse effects and that removing safeguards would exacerbate ethical and societal risks associated with chemical abortion.

Dr. Peter Rosario, a medical professional, opposes the proposed changes to mifepristone's REMS and EASU oversight. He argues that the medication has more deleterious effects than previously reported and cites concerns regarding the underreporting of adverse effects and the ethical implications of chemical abortions.

Adele Kootz expresses strong opposition to the proposed action, arguing that the FDA should not weaken safety protocols or remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. She cites concerns regarding the drug's safety, potential for abuse, and its impact on women's health, urging the FDA to maintain and strengthen current regulations.

The commenter urges the FDA to reject the citizen petition filed by the Attorney General of Massachusetts. They argue that chemical abortions have significant underreported adverse effects and ethical concerns, and they recommend reinstating stricter REMS safety standards for mifepristone.

The Catholic Medical Association opposes the petition to reduce or eliminate FDA safety regulations on mifepristone, arguing that such changes would exacerbate risks to women's health and violate ethical standards. They advocate for strengthening current safeguards, including mandatory in-person consultations and more comprehensive reporting of adverse effects.

The Catholic Medical Association opposes the loosening of safeguards around the abortion pill, specifically citing risks associated with telemedicine and a lack of informed consent regarding complications and alternatives. They advocate for stricter regulations, including mandatory in-person consultations, reporting of all adverse effects, and the disclosure of abortion reversal options.

A family physician from New Hampshire supports the Catholic Medical Association's opposition to the proposed action. The commenter argues that the current regulations on misoprostol are insufficient for patient safety and advocates for stricter oversight and more comprehensive informed consent.